retatrutide
A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
PubMed · Publication · 2026-06-01T00:00:00
Research Summary
Retatrutide is a novel triple agonist that targets the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R).
At present, its synthesis relies predominantly on solid-phase peptide synthesis (SPPS), an approach that suffers from inherent limitations in terms of efficiency, scalability, and structural flexibility.
In this study, we present a novel method for the synthesis of Retatrutide, namely hydrophobic tag-assisted liquid-phase peptide synthesis (LPPS).
This method provides a practical and flexible alternative to conventional SPPS for the synthesis of Retatrutide..
Paper Metadata
Compound: retatrutide
Journal: Organic letters
Source: PubMed
Type: Publication
Published: 2026 Jun 1
PubMed ID: 42224238
Authors
Mao CY, Pang ZJ, Qiao GY, Dong L
Research Radar Analysis
AI analysis has not been generated for this paper yet.